Andrew Paterson

Senior Vice President, Head of U.S. and Global MS Franchise


In his role, Andrew oversees all commercial operations for the franchise in the US and also leads global marketing efforts for our MS therapies. 

In his 23 years with the company, Andrew Paterson has held positions in Local, Regional and Global commercial functions across a variety of therapeutic areas including Neurology, Endocrinology, Fertility and Cardio-vascular.

Andrew began his career with Merck KGaA, Darmstadt, Germany in 1998 as a Medical Sales Representative in the UK. He subsequently took on roles of increasing responsibility including first line Sales Manager, Marketing Manager and Business Unit Director. Global and Regional leadership roles followed. Most recently, his focus was on the preparation and execution of the global launch of a new therapy in MS and progressing pipeline therapies toward commercialization.

Andrew holds a BSc (Hons) in Biological Science from the University of Edinburgh and an Executive MBA from Ashridge Management College.


You have accessed, but for users from your part of the world, we originally designed the following web presence

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement